Advice for consumers

AI Summary

This guidance from the UK Medicines and Healthcare products Regulatory Agency (MHRA) outlines the procedures for monitoring safety and verifying the legal status of e-cigarette products in the United Kingdom. Central to this regulatory framework is the Yellow Card scheme, which allows consumers and healthcare professionals to report adverse health reactions. These reports are analyzed by a specialized team of scientists and medical professionals to identify potential safety patterns and determine if regulatory intervention is required to safeguard the public. Data regarding these reports is publicly accessible via the e-cigarette Analysis Print, though the MHRA notes that these records represent suspected side effects rather than confirmed causal links. To ensure consumer safety, the MHRA maintains a comprehensive database of products that have been successfully notified for sale in Great Britain and Northern Ireland. The guidance stresses that e-cigarettes are only legally compliant for supply once they appear on this official list. Consumers are advised to use the MHRA publication home page to verify brands and product types before purchase. If a consumer identifies or purchases a non-compliant product that cannot be returned to the retailer, the MHRA instructs them to contact their local Trading Standards service. Furthermore, concerns regarding product quality or general safety are shared with the Office for Health Improvement and Disparities to ensure broad regulatory oversight.